246 related articles for article (PubMed ID: 24891219)
21. Ostm1 Bifunctional Roles in Osteoclast Maturation: Insights From a Mouse Model Mimicking a Human OSTM1 Mutation.
Pata M; Vacher J
J Bone Miner Res; 2018 May; 33(5):888-898. PubMed ID: 29297601
[TBL] [Abstract][Full Text] [Related]
22. OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.
Ishii T; Ruiz-Torruella M; Ikeda A; Shindo S; Movila A; Mawardi H; Albassam A; Kayal RA; Al-Dharrab AA; Egashira K; Wisitrasameewong W; Yamamoto K; Mira AI; Sueishi K; Han X; Taubman MA; Miyamoto T; Kawai T
FASEB J; 2018 Jul; 32(7):4016-4030. PubMed ID: 29533736
[TBL] [Abstract][Full Text] [Related]
23. Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts.
Zeng Z; Zhang C; Chen J
J Bone Miner Metab; 2013 Jul; 31(4):409-16. PubMed ID: 23525827
[TBL] [Abstract][Full Text] [Related]
24. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
[TBL] [Abstract][Full Text] [Related]
25. Pin1, the Master Orchestrator of Bone Cell Differentiation.
Islam R; Yoon WJ; Ryoo HM
J Cell Physiol; 2017 Sep; 232(9):2339-2347. PubMed ID: 27225727
[TBL] [Abstract][Full Text] [Related]
26. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
[TBL] [Abstract][Full Text] [Related]
27. An essential role for STAT6-STAT1 protein signaling in promoting macrophage cell-cell fusion.
Miyamoto H; Katsuyama E; Miyauchi Y; Hoshi H; Miyamoto K; Sato Y; Kobayashi T; Iwasaki R; Yoshida S; Mori T; Kanagawa H; Fujie A; Hao W; Morioka H; Matsumoto M; Toyama Y; Miyamoto T
J Biol Chem; 2012 Sep; 287(39):32479-84. PubMed ID: 22865856
[TBL] [Abstract][Full Text] [Related]
28. MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner.
Miyamoto K; Ninomiya K; Sonoda KH; Miyauchi Y; Hoshi H; Iwasaki R; Miyamoto H; Yoshida S; Sato Y; Morioka H; Chiba K; Egashira K; Suda T; Toyama Y; Miyamoto T
Biochem Biophys Res Commun; 2009 Jun; 383(3):373-7. PubMed ID: 19364494
[TBL] [Abstract][Full Text] [Related]
29. Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells.
Yagi M; Miyamoto T; Toyama Y; Suda T
J Bone Miner Metab; 2006; 24(5):355-8. PubMed ID: 16937266
[TBL] [Abstract][Full Text] [Related]
30. Mechanical vibration inhibits osteoclast formation by reducing DC-STAMP receptor expression in osteoclast precursor cells.
Kulkarni RN; Voglewede PA; Liu D
Bone; 2013 Dec; 57(2):493-8. PubMed ID: 23994170
[TBL] [Abstract][Full Text] [Related]
31. Inorganic phosphate-induced impairment of osteoclast cell-cell fusion by the inhibition of AP-1-mediated DC-STAMP expression.
Arioka M; Takahashi-Yanaga F; Tatsumoto N; Sasaguri T
Biochem Biophys Res Commun; 2017 Nov; 493(1):9-13. PubMed ID: 28939042
[TBL] [Abstract][Full Text] [Related]
32. Ostm1 from Mouse to Human: Insights into Osteoclast Maturation.
Vacher J; Bruccoleri M; Pata M
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764302
[TBL] [Abstract][Full Text] [Related]
33. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
[TBL] [Abstract][Full Text] [Related]
34. HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function.
Wu J; Glimcher LH; Aliprantis AO
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):16934-9. PubMed ID: 18971331
[TBL] [Abstract][Full Text] [Related]
35. Pin1 null mice exhibit low bone mass and attenuation of BMP signaling.
Shen ZJ; Hu J; Ali A; Pastor J; Shiizaki K; Blank RD; Kuro-o M; Malter JS
PLoS One; 2013; 8(5):e63565. PubMed ID: 23675491
[TBL] [Abstract][Full Text] [Related]
36. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
37. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
Chu K; Snyder R; Econs MJ
J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
[TBL] [Abstract][Full Text] [Related]
38. Role of CSF-1 in bone and bone marrow development.
Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
[TBL] [Abstract][Full Text] [Related]
39. Cell-surface phosphatidylserine regulates osteoclast precursor fusion.
Verma SK; Leikina E; Melikov K; Gebert C; Kram V; Young MF; Uygur B; Chernomordik LV
J Biol Chem; 2018 Jan; 293(1):254-270. PubMed ID: 29101233
[TBL] [Abstract][Full Text] [Related]
40. Regulation of bone mass and osteoclast function depend on the F-actin modulator SWAP-70.
Garbe AI; Roscher A; Schüler C; Lutter AH; Glösmann M; Bernhardt R; Chopin M; Hempel U; Hofbauer LC; Rammelt S; Egerbacher M; Erben RG; Jessberger R
J Bone Miner Res; 2012 Oct; 27(10):2085-96. PubMed ID: 22648978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
